|
Kukushkina A.D., Davydovskaya M.V., Khachanova N.V., Popova E.V., Ponevezhskaya E.V., Lysogorskaya E.V.
A case of rebound effect when switching from natalizumab to another highly effective drug in a patient with multiple sclerosis
|
№6 / 2024
|
|
K.Yu. Zherebchikova, A.S. Ermolaeva, Yu.P. Sych, V.V. Fadeev
Features of the differential diagnosis of thyropathies induced by monoclonal antibodies: a clinical case
|
№4 / 2022
|
|
P.G. Shvarts (1), S.V. Popov (2), I.A. Zavalishin (1)
PATHOPHYSIOLOGICAL AND NEUROPHARMACOLOGICAL FEATURES OF THERAPY OF CHRONIC RETENTION OF URINE IN MULTIPLE SCLEROSIS
|
№6 / 2017
|
|
M.A. Kurapov (1), Ya.V. Vlasov (2)
PHARMACOTHERAPY OF MULTIPLE SCLEROSIS: TREATMENT OF EXACERBATIONS, IMMUNOMODULATORY THERAPY
|
№s4-16 / 2016
|
|
S.V. Popov
ERECTILE DYSFUNCTION AGAINST THE BACKGROUND OF CENTRAL NERVOUS SYSTEM DISEASES
|
№19 / 2014
|
|
S.V.Tarasova, MD, M.A.Kurapov
EXPERIENCE OF THE USE OF THIOCTIC ACID IN COMPLEX TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS EXACERBATIONS
|
№19 / 2014
|
|
R.Ts.Bembeeva (1), K.I.Kirgizov (2, 3), E.I.Skorobogatova (2), E.Yu.Volkova (2)
APPROACHES TO THE THERAPY OF REFRACTORY MULTIPLE SCLEROSIS IN CHILDREN
|
№7 / 2014
|
|
O.V. Trifonova, I.A. Zavalishin С. 5154
Modern Methods Of Pathogenetic Therapy Of Multiple Sclerosis
|
№7 / 2009
|
Русский
